PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.57%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-27.63%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-30.80%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-28.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-28.45%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-28.45%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
86.76%
10Y CAGR of 86.76% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
86.76%
5Y CAGR of 86.76% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
54.48%
3Y revenue/share CAGR above 1.5x 3391.T's 19.66%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
206.94%
10Y net income/share CAGR of 206.94% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
206.94%
Net income/share CAGR of 206.94% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
61.89%
3Y net income/share CAGR 1.25-1.5x 3391.T's 46.90%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
126.07%
Equity/share CAGR of 126.07% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
126.07%
Equity/share CAGR of 126.07% while 3391.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.28%
Inventory growth well above 3391.T's 0.69%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.72%
Asset growth above 1.5x 3391.T's 3.84%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.46%
BV/share growth above 1.5x 3391.T's 3.55%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-18.56%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.